BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32525545)

  • 1. Host Factors Independently Associated With Prognosis in Patients With Oral Cavity Cancer.
    Valero C; Zanoni DK; Pillai A; Ganly I; Morris LGT; Shah JP; Wong RJ; Patel SG
    JAMA Otolaryngol Head Neck Surg; 2020 Aug; 146(8):699-707. PubMed ID: 32525545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment peripheral blood leukocytes are independent predictors of survival in oral cavity cancer.
    Valero C; Zanoni DK; McGill MR; Ganly I; Morris LGT; Quer M; Shah JP; Wong RJ; León X; Patel SG
    Cancer; 2020 Mar; 126(5):994-1003. PubMed ID: 31809562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Performance of a New Staging Category to Improve Discrimination of Disease-Specific Survival in Nonmetastatic Oral Cancer.
    Lee CC; Huang CY; Lin YS; Chang KP; Chi CC; Lin MY; Su HH; Chang TS; Chen HC; Yang CC
    JAMA Otolaryngol Head Neck Surg; 2017 Apr; 143(4):395-402. PubMed ID: 28125757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative prognostic value of different preoperative complete blood count cell ratios in patients with oral cavity cancer treated with surgery and postoperative radiotherapy.
    Wu YY; Chang KP; Ho TY; Chou WC; Hung SP; Fan KH; Chiang YY; Chou YC; Tsang NM
    Cancer Med; 2021 Mar; 10(6):1975-1988. PubMed ID: 33624454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment serum lactate dehydrogenase as a prognostic indicator for oral cavity squamous cell carcinoma.
    Takenaka Y; Oya R; Aoki K; Hamaguchi H; Takemura K; Nozawa M; Kitamura T; Yamamoto Y; Uno A
    Acta Otolaryngol; 2018 Apr; 138(4):433-436. PubMed ID: 29233054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node ratio as prognostic variable in oral squamous cell carcinomas: Systematic review and meta-analysis.
    Huang TH; Li KY; Choi WS
    Oral Oncol; 2019 Feb; 89():133-143. PubMed ID: 30732951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Lymph Node Ratio and Recurrence and Survival Outcomes in Patients With Oral Cavity Cancer.
    Ding D; Stokes W; Eguchi M; Hararah M; Sumner W; Amini A; Goddard J; Somerset H; Bradley C; McDermott J; Raben D; Karam SD
    JAMA Otolaryngol Head Neck Surg; 2019 Jan; 145(1):53-61. PubMed ID: 30452499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative circulating platelet, neutrophil, and lymphocyte counts predict survival in oral cancer.
    Diao P; Wu Y; Ge H; Li J; Zhang W; Huang R; Wang Y; Cheng J
    Oral Dis; 2019 May; 25(4):1057-1066. PubMed ID: 30697882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between the diagnosis-to-treatment interval and overall survival in Taiwanese patients with oral cavity squamous cell carcinoma.
    Liao CT; Chen HN; Wen YW; Lee SR; Ng SH; Liu TW; Tsai ST; Tsai MH; Lin JC; Lou PJ; Wang CP; Chu PY; Leu YS; Tsai KY; Terng SD; Chen TM; Wang CH; Chien CY; Chen WC; Lee LY; Lin CY; Wang HM; Lin CH; Fang TJ; Huang SF; Kang CJ; Chang KP; Yang LY; Yen TC
    Eur J Cancer; 2017 Feb; 72():226-234. PubMed ID: 28056426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients.
    Rot S; Kaune T; Taubert H; Greither T; Kotrba J; Güttler A; Wichmann H; Bilkenroth U; Wienke A; Al-Nawas B; Bache M; Vordermark D; Wickenhauser C; Bethmann D; Eckert AW; Kappler M
    BMC Cancer; 2019 Feb; 19(1):155. PubMed ID: 30770730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated Serum Gas6 Is a Novel Prognostic Biomarker in Patients with Oral Squamous Cell Carcinoma.
    Jiang T; Liu G; Wang L; Liu H
    PLoS One; 2015; 10(7):e0133940. PubMed ID: 26207647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Ultra-Deep Targeted Sequencing Gene Panel Improves the Prognostic Stratification of Patients With Advanced Oral Cavity Squamous Cell Carcinoma.
    Liao CT; Chen SJ; Lee LY; Hsueh C; Yang LY; Lin CY; Fan KH; Wang HM; Ng SH; Lin CH; Tsao CK; Chen IH; Chang KP; Huang SF; Kang CJ; Chen HC; Yen TC
    Medicine (Baltimore); 2016 Feb; 95(8):e2751. PubMed ID: 26937903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of the preoperative systemic immune-inflammation index in patients with oral cavity squamous cell carcinoma treated with curative surgery and adjuvant therapy.
    Hung SP; Chen PR; Ho TY; Chang KP; Chou WC; Lee CH; Wu YY; Chen PJ; Lin CH; Chou YC; Fan KH; Lin CY; Huang BS; Tung-Chieh Chang J; Wang CC; Tsang NM
    Cancer Med; 2021 Jan; 10(2):649-658. PubMed ID: 33325655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcopenia results in poor survival rates in oral cavity cancer patients.
    Lin SC; Lin YS; Kang BH; Yin CH; Chang KP; Chi CC; Lin MY; Su HH; Chang TS; She YY; Liu YH; Lee CC
    Clin Otolaryngol; 2020 May; 45(3):327-333. PubMed ID: 31769607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of serum liver enzymes in oral and oropharynx squamous cell carcinomas.
    Zhu Z; Zhou J; Xiong X; Liu D; Zheng Y; Ding X; Du Y; Gu N; Wu Y; Song X
    J Oral Pathol Med; 2019 Jan; 48(1):36-42. PubMed ID: 30447114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of the prognostic value of the neutrophil-to-lymphocyte ratio in oral squamous cell carcinoma.
    Wang Y; Wang P; Andrukhov O; Wang T; Song S; Yan C; Zhang F
    J Oral Pathol Med; 2018 Apr; 47(4):353-358. PubMed ID: 29406591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity and genes related to lipid metabolism predict poor survival in oral squamous cell carcinoma.
    Hu Q; Peng J; Chen X; Li H; Song M; Cheng B; Wu T
    Oral Oncol; 2019 Feb; 89():14-22. PubMed ID: 30732952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival outcomes after treatment of cancer of the oral cavity (1985-2015).
    Zanoni DK; Montero PH; Migliacci JC; Shah JP; Wong RJ; Ganly I; Patel SG
    Oral Oncol; 2019 Mar; 90():115-121. PubMed ID: 30846169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome analysis of patients with well-differentiated oral cavity squamous cell carcinoma.
    Kang CJ; Liao CT; Hsueh C; Lee LY; Lin CY; Fan KH; Wang HM; Huang SF; Chen IH; Ng SH; Tsao CK; Huang YC; Yen TC
    Oral Oncol; 2011 Nov; 47(11):1085-91. PubMed ID: 21840751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
    Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
    Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.